Hosted on MSN
Flibanserin and the journey to rediscover desire
Flibanserin, marketed as Addyi, is the first FDA-approved drug for treating hypoactive sexual desire disorder (HSDD) in premenopausal women. Clinical trials show it can modestly increase sexual desire ...
TIME has named Sprout Pharmaceuticals among just 10 organizations globally shaping the future of health and life sciences.
Industry Leaders lists, an expansion of the TIME100 Most Influential Companies issue that dives deeper into 20 sectors to ...
Epic Systems was named to Time’s list of the most influential health and life sciences companies of 2026. The ranking, released April 27, is part of Time’s expanded TIME100 Companies franchise, which ...
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results